Biocon and Viatris to distribute Insulin Glargine through Walgreens in US

While Viatris has commercialisation rights for the US, Canada, Australia, EU and others, Biocon will be able to commercialise the products in Japan and some emerging markets. Other global markets have been split among the two partners to serve the rest of the world.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news